EP3672609A4 - Activateurs monoterpènes de l'aldéhyde déshydrogénase 3a1 et leurs procédés d'utilisation - Google Patents

Activateurs monoterpènes de l'aldéhyde déshydrogénase 3a1 et leurs procédés d'utilisation Download PDF

Info

Publication number
EP3672609A4
EP3672609A4 EP18847514.9A EP18847514A EP3672609A4 EP 3672609 A4 EP3672609 A4 EP 3672609A4 EP 18847514 A EP18847514 A EP 18847514A EP 3672609 A4 EP3672609 A4 EP 3672609A4
Authority
EP
European Patent Office
Prior art keywords
monoterpen
activators
aldehyde dehydrogenase
dehydrogenase
aldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18847514.9A
Other languages
German (de)
English (en)
Other versions
EP3672609A1 (fr
Inventor
Julie SAIKI
Che-Hong Chen
Quynh-Thu Le
Daria Mochly-Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of EP3672609A1 publication Critical patent/EP3672609A1/fr
Publication of EP3672609A4 publication Critical patent/EP3672609A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0633—Cells of secretory glands, e.g. parotid gland, salivary glands, sweat glands, lacrymal glands
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1094—Shielding, protecting against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/71—Oxidoreductases (EC 1.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP18847514.9A 2017-08-24 2018-08-23 Activateurs monoterpènes de l'aldéhyde déshydrogénase 3a1 et leurs procédés d'utilisation Withdrawn EP3672609A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762549849P 2017-08-24 2017-08-24
PCT/US2018/047791 WO2019040772A1 (fr) 2017-08-24 2018-08-23 Activateurs monoterpènes de l'aldéhyde déshydrogénase 3a1 et leurs procédés d'utilisation

Publications (2)

Publication Number Publication Date
EP3672609A1 EP3672609A1 (fr) 2020-07-01
EP3672609A4 true EP3672609A4 (fr) 2021-08-11

Family

ID=65436411

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18847514.9A Withdrawn EP3672609A4 (fr) 2017-08-24 2018-08-23 Activateurs monoterpènes de l'aldéhyde déshydrogénase 3a1 et leurs procédés d'utilisation

Country Status (4)

Country Link
US (1) US20190060249A1 (fr)
EP (1) EP3672609A4 (fr)
JP (1) JP2020531518A (fr)
WO (1) WO2019040772A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011109635A1 (fr) * 2010-03-03 2011-09-09 Neonc Technologies Inc. Compositions pharmaceutiques comprenant des monoterpènes
WO2012149106A1 (fr) * 2011-04-29 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Compositions et procédés d'augmentation de la prolifération de cellules souches salivaires adultes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056491B2 (en) * 2000-11-08 2006-06-06 Wisconsin Alumni Research Foundation Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators
ES2600928T3 (es) * 2010-08-27 2017-02-13 Neonc Technologies Inc. Composiciones farmacéuticas que comprenden derivados de alcohol perilílico
JP2016503004A (ja) * 2012-12-11 2016-02-01 ティロシュ，ピーター 癌のための併用療法
US20150283072A1 (en) * 2014-03-20 2015-10-08 Santé, Llc Pre-operative beverages

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011109635A1 (fr) * 2010-03-03 2011-09-09 Neonc Technologies Inc. Compositions pharmaceutiques comprenant des monoterpènes
WO2012149106A1 (fr) * 2011-04-29 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Compositions et procédés d'augmentation de la prolifération de cellules souches salivaires adultes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2019040772A1 *

Also Published As

Publication number Publication date
US20190060249A1 (en) 2019-02-28
JP2020531518A (ja) 2020-11-05
EP3672609A1 (fr) 2020-07-01
WO2019040772A1 (fr) 2019-02-28

Similar Documents

Publication Publication Date Title
EP3704254A4 (fr) Compositions de cas12c et procédés d'utilisation
EP3583406C0 (fr) Biocapteur plamo-photonique intégré et procédé d'utilisation
EP3721086A4 (fr) Dispositifs de régulation de fluide et leurs procédés d'utilisation
EP3641868A4 (fr) Gaine extensible et méthodes d'utilisation de celle-ci
EP3310378C0 (fr) Anticorps anti-c1 et leurs procédés d'utilisation
EP3496859C0 (fr) Sonde de collecte et son procédé d'utilisation
EP3526256C0 (fr) Anticorps anti-lag-3 et leurs procédés d'utilisation
EP3970680C0 (fr) Station de technologie médicale et procédé d'utilisation
EP3526907C0 (fr) Procédés d'adaptation de densité de signaux de référence de démodulation
EP3600372A4 (fr) Compositions de synthékine et procédés d'utilisation
EP3600716A4 (fr) Joints en x et procédés de fabrication
EP3630949A4 (fr) Compositions et procédés d'obtention d'organoïdes
EP3558475A4 (fr) Tapis de course à utilisation assise et son procédé d'utilisation
EP3600171A4 (fr) Cathéters à ballonnet et procédés d'utilisation
EP3922649C0 (fr) Anticorps anti-htra1 et leurs procédés d'utilisation
EP3728268A4 (fr) Inhibiteurs de nek et procédés d'utilisation
EP3562931A4 (fr) Dispositifs de détection microbienne et leurs procédés d'utilisation
EP3448876C0 (fr) Mutéines de streptavidine et méthodes d'utilisation associées
EP3526334A4 (fr) Variants de l'endonucléase tgfbéta r2, compositions et procédés d'utilisation
EP3548484C0 (fr) Composés amide bicycliques et leurs procédés d'utilisation
EP3534710A4 (fr) Compositions d'enrobage et leurs procédés d'utilisation
EP3518910A4 (fr) Compositions de midodrine et leurs procédés d'utilisation
EP3512686A4 (fr) Plateau applicateur de recouvrement et son procédé d'utilisation
EP3506982A4 (fr) Inhibiteurs de mif et leurs méthodes d'utilisation
EP3579860A4 (fr) Anticorps anti-trailshort et méthodes d'utilisation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200220

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210713

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/015 20060101AFI20210707BHEP

Ipc: A61K 31/045 20060101ALI20210707BHEP

Ipc: A61P 27/02 20060101ALI20210707BHEP

Ipc: A61P 35/00 20060101ALI20210707BHEP

Ipc: C12N 5/0797 20100101ALI20210707BHEP

Ipc: C12N 5/071 20100101ALI20210707BHEP

Ipc: G01N 33/574 20060101ALI20210707BHEP

Ipc: A61N 5/10 20060101ALI20210707BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220210